Holen Sie sich die Stockscreener-App
4.31
1.93%
-0.10
Schlusskurs vom Vortag:
$4.41
Offen:
$4.49
24-Stunden-Volumen:
916.83K
Relative Volume:
0.79
Marktkapitalisierung:
$267.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.81M
KGV:
-2.2926
EPS:
-1.88
Netto-Cashflow:
$74.30M
1W Leistung:
+4.47%
1M Leistung:
+28.72%
6M Leistung:
-53.69%
1J Leistung:
+6.00%
1-Tages-Spanne:
$4.295
$4.545
1-Wochen-Bereich:
$4.02
$4.545
52-Wochen-Spanne:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Firmenname
Omeros Corporation
Sektor
Branche
Telefon
206-676-5000
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Vergleichen Sie OMER mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
4.325 | 296.03M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.65 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.20 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.20 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.08 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
322.48 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-12-08 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2021-10-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-09-27 | Eingeleitet | JP Morgan | Neutral |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-08-21 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-14 | Bestätigt | Maxim Group | Buy |
| 2019-05-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-03-05 | Herabstufung | Needham | Buy → Hold |
| 2017-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Bestätigt | Maxim Group | Buy |
| 2017-03-17 | Bestätigt | Needham | Buy |
| 2016-11-16 | Bestätigt | Wedbush | Outperform |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-06-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-02 | Bestätigt | Needham | Buy |
| 2016-02-29 | Bestätigt | Wedbush | Outperform |
| 2015-11-11 | Bestätigt | Needham | Buy |
| 2015-08-18 | Bestätigt | WBB Securities | Strong Buy |
| 2015-08-10 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Omeros Corporation Aktie (OMER) Neueste Nachrichten
Omeros Q2 Earnings Miss Highlight Market Resilience and Rebound Potential - AInvest
Omeros Corp Maintains 'Buy' Rating with $36 Price Target: D. Boral Capital. - AInvest
Needham Maintains Hold Rating on Omeros Stock - AInvest
Omeros Reports Q2 2025 Financial Results, Net Loss Down to $25.4mln - AInvest
What indicators show strength in Omeros CorporationWeekly Loss Report & Community Driven Trade Alerts - Newser
Does Omeros Corporation qualify in momentum factor screeningCPI Data & Weekly Breakout Stock Alerts - Newser
D. Boral Capital Reiterates Buy Rating for Omeros (NASDAQ:OMER) - Defense World
Omeros (NASDAQ:OMER) Earns Hold Rating from Needham & Company LLC - Defense World
Real time scanner hits for Omeros Corporation explainedJuly 2025 Patterns & Fast Moving Trade Plans - Newser
What are Omeros Corporation’s recent SEC filings showingMarket Trend Summary & Weekly Setup with ROI Potential - thegnnews.com
Omeros Corporation stock daily chart insightsQuarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
Is Omeros Corporation a Top Dividend Stock to Watch in 2025Share Buyback & Weekly Watchlist for Consistent Profits - Newser
Real Time Data Flags Unusual Activity in Omeros Corporation2025 Stock Rankings & Precise Trade Entry Recommendations - newsyoung.net
Omeros: Q2 Earnings Snapshot - Norwalk Hour
Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ... - Yahoo Finance
Omeros Posts 2,652 Percent Sales Jump - AOL.com
Omeros Corporation Reports Q2 2025 Financial Results - TipRanks
Transcript : Omeros Corporation, Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Earnings call transcript: Omeros beats Q2 2025 EPS forecast, stock dips - Investing.com Nigeria
Omeros Corporation Reports Second Quarter 2025 Financial Results - Placera.se
Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025 - MarketScreener
Omeros Corporation to Announce Q2 Financial Results on August 14, 2025 - AInvest
Can Omeros Corporation rally from current levelsShort Term Profit Strategy with Entry Cues - Newser
What makes Omeros Corporation stock price move sharplyDaily Market Momentum and Pressure Analysis - Newser
Omeros Corporation’s Price Action Aligns with Quant SignalsRisk Managed Intraday Trade Alerts Increase in Volume - 선데이타임즈
Press Release: Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025 - 富途牛牛
Omeros Announces Q2 2025 Earnings Release and Conference Call on August 14 - AInvest
A&O Shearman advises D. Boral Capital LLC on USD22 million registered direct offering of Omeros Corporation - A&O Shearman
Omeros Announces Q2 2025 Earnings Release and Conference Call Details for August 14 - Stock Titan
Will earnings trigger a reversal in Omeros CorporationPrice Forecast Based on AI Analysis - Newser
Does Omeros Corporation fit your quant trading modelBuy Candidate Summary Based on Fundamentals - Newser
Volatility clustering patterns for Omeros CorporationFree Exit Ready Momentum Stock Watchlist - Newser
Best data tools to analyze Omeros Corporation stockWeekly Stock Movement Prediction Watchlist - Newser
How institutional ownership impacts Omeros Corporation stockLong-Term Trend Tracking and Signal Summary - Newser
Omeros Corporation shares rise 1.32% premarket after positive investor sentiment in Europe. - AInvest
Omeros Corporation (NASDAQ:OMER) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Seattle biopharma raises $22 million through stock sale - The Business Journals
Omeros announces pricing of $22 million registered direct offering - MSN
Omeros Corporation Stock Analysis and ForecastGet daily expert analysis for smarter investing - Jammu Links News
What is the dividend policy of Omeros Corporation stockConsistent triple returns - Jammu Links News
Omeros rises after pricing ~$22M stock offering - MSN
What institutional investors are buying Omeros Corporation stockMassive wealth growth - Jammu Links News
How strong is Omeros Corporation company’s balance sheetExceptional trading performance - Jammu Links News
What catalysts could drive Omeros Corporation stock higher in 2025Discover stocks with explosive upside potential - Jammu Links News
Why is Omeros Corporation stock attracting strong analyst attentionFree Stock Movement Tracking - Jammu Links News
How many analysts rate Omeros Corporation as a “Buy”Proven strategies for superior portfolio growth - Jammu Links News
How volatile is Omeros Corporation stock compared to the marketFree Trading Strategy Suggestions - Jammu Links News
When is Omeros Corporation stock expected to show significant growthPhenomenal investment performance - Jammu Links News
Is Omeros Corporation a good long term investmentAchieve rapid portfolio growth with smart picks - Jammu Links News
What is Omeros Corporation company’s growth strategyGet daily updates on promising stocks - Jammu Links News
Narsoplimab Study Insights Could Boost Omeros (OMER) Amid Eculizumab Concerns - AInvest
Finanzdaten der Omeros Corporation-Aktie (OMER)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):